Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes

2016627 citationsReview

Authors

Sasha E. Stanton · Institute of Translational Health Sciences

Mary L. Disis · University of Washington

Abstract

The magnitude of TIL is variable within and between breast cancer subtypes. Levels of lymphocytic subpopulations may identify breast cancers more amenable to immunomodulation and indicate additional strategies to enhance immunity in patients with low to moderate levels of TILs.

Topics & Keywords

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses Immune Cell Function and Interaction

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA Oncology

Volume 2, Issue 10, pp. 1354-1354

DOI: 10.1001/jamaoncol.2016.1061

Field-Weighted Citation Impact: 17.67